News
The average CTC increased to Rs 29.57 lakh per annum, while the highest domestic offer stood at Rs 70 LPA. Last year, the ...
Last week, President Trump sent letters to 17 major pharmaceutical companies advising them to work with his administration to ...
Trump signed an executive order on his first day in office in January seeking to “maximize the development and production of ...
Drugmaker Eli Lilly says its oral, daily GLP-1 pill may offer similar weight loss results as weekly GLP-1 shots.
Eli Lilly (LLY) has recently launched SenderraCare+, a digital solution paired with its biologic treatment EBGLYSS, and announced positive outcomes from a Phase 3 trial for the weight management drug ...
Eli Lilly's orforglipron missed weight loss targets in a Phase 3 trial, but strong Q2 results and raised guidance highlight ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results